Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
[Cancer Research 60, 5037-5039, September 15, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Ataxia Telangiectasia-related Protein Is Involved in the Phosphorylation of BRCA1 following Deoxyribonucleic Acid Damage1

Junjie Chen2

Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905

The breast/ovarian cancer susceptibility gene BRCA1 exerts its tumor suppressor function, at least in part, by participating in DNA repair and/or DNA damage-responsive pathways. BRCA1 protein is hyperphosphorylated following various DNA-damaging events. Here, we report that the ataxia telangiectasia mutated protein-related protein kinase (ATR) is involved in the phosphorylation of BRCA1 following gamma radiation and hydroxyurea treatment. We have shown that ATR can phosphorylate several BRCA1 fragments in vitro and that a kinase-inactive mutant of ATR interacts with BRCA1 in vivo. Taken together, these results suggest that ATR directly phosphorylates BRCA1 following DNA damage.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Yan, C. P. Black, P. T. Cao, J. L. Haferbier, R. H. Kolb, R. S. Spieker, A. M. Ristow, and K. H. Cowan
{gamma}-Irradiation-Induced DNA Damage Checkpoint Activation Involves Feedback Regulation between Extracellular Signal-Regulated Kinase 1/2 and BRCA1
Cancer Res., July 1, 2008; 68(13): 5113 - 5121.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. I. Yarden and M. Z. Papa
BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions.
Mol. Cancer Ther., June 1, 2006; 5(6): 1396 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. P. Schlegel, F. M. Jodelka, and R. Nunez
BRCA1 Promotes Induction of ssDNA by Ionizing Radiation.
Cancer Res., May 15, 2006; 66(10): 5181 - 5189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Dodson and R. S. Tibbetts
DNA Replication Stress-induced Phosphorylation of Cyclic AMP Response Element-binding Protein Mediated by ATM
J. Biol. Chem., January 20, 2006; 281(3): 1692 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Zhang and S. N. Powell
The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair
Mol. Cancer Res., October 1, 2005; 3(10): 531 - 539.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Yu and J. Chen
DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains
Mol. Cell. Biol., November 1, 2004; 24(21): 9478 - 9486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Feng, L. Kachnic, J. Zhang, S. N. Powell, and F. Xia
DNA Damage Induces p53-dependent BRCA1 Nuclear Export
J. Biol. Chem., July 2, 2004; 279(27): 28574 - 28584.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Kote-Jarai, R. D. Williams, N. Cattini, M. Copeland, I. Giddings, R. Wooster, R. H. tePoele, P. Workman, B. Gusterson, J. Peacock, et al.
Gene Expression Profiling after Radiation-Induced DNA Damage Is Strongly Predictive of BRCA1 Mutation Carrier Status
Clin. Cancer Res., February 1, 2004; 10(3): 958 - 963.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. A. Rao and W. Plunkett
Activation of a p53-mediated Apoptotic Pathway in Quiescent Lymphocytes after the Inhibition of DNA Repair by Fludarabine
Clin. Cancer Res., August 1, 2003; 9(8): 3204 - 3212.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Franchitto, J. Oshima, and P. Pichierri
The G2-phase Decatenation Checkpoint Is Defective in Werner Syndrome Cells
Cancer Res., June 15, 2003; 63(12): 3289 - 3295.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Lafarge and M.-H. Montane
Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays
Nucleic Acids Res., February 15, 2003; 31(4): 1148 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Okada and T. Ouchi
Cell Cycle Differences in DNA Damage-induced BRCA1 Phosphorylation Affect Its Subcellular Localization
J. Biol. Chem., January 10, 2003; 278(3): 2015 - 2020.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Liu, D. M. Virshup, R. L. White, and L.-C. Hsu
Regulation of BRCA1 Phosphorylation by Interaction with Protein Phosphatase 1{alpha}
Cancer Res., November 15, 2002; 62(22): 6357 - 6361.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Taniguchi, I. Garcia-Higuera, P. R. Andreassen, R. C. Gregory, M. Grompe, and A. D. D'Andrea
S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51
Blood, September 18, 2002; 100(7): 2414 - 2420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Muto, Y. Kanari, E. Kubo, T. Takabe, T. Kurihara, A. Fujimori, and K. Tatsumi
Targeted Disruption of Np95 Gene Renders Murine Embryonic Stem Cells Hypersensitive to DNA Damaging Agents and DNA Replication Blocks
J. Biol. Chem., September 6, 2002; 277(37): 34549 - 34555.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Edwards, L. Geng, J. Tan, H. Onishko, E. Donnelly, and D. E. Hallahan
Phosphatidylinositol 3-Kinase/Akt Signaling in the Response of Vascular Endothelium to Ionizing Radiation
Cancer Res., August 15, 2002; 62(16): 4671 - 4677.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Yamane, X. Wu, and J. Chen
A DNA Damage-Regulated BRCT-Containing Protein, TopBP1, Is Required for Cell Survival
Mol. Cell. Biol., January 15, 2002; 22(2): 555 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. M. Ward and J. Chen
Histone H2AX Is Phosphorylated in an ATR-dependent Manner in Response to Replicational Stress
J. Biol. Chem., December 14, 2001; 276(51): 47759 - 47762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. St.Onge, B. D. A. Besley, M. Park, R. Casselman, and S. Davey
DNA Damage-dependent and -independent Phosphorylation of the hRad9 Checkpoint Protein
J. Biol. Chem., November 2, 2001; 276(45): 41898 - 41905.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Menoyo, H. Alazzouzi, E. Espin, M. Armengol, H. Yamamoto, and S. Schwartz Jr.
Somatic Mutations in the DNA Damage-Response Genes ATR and CHK1 in Sporadic Stomach Tumors with Microsatellite Instability
Cancer Res., November 1, 2001; 61(21): 7727 - 7730.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. B. Deming, C. A. Cistulli, H. Zhao, P. R. Graves, H. Piwnica-Worms, R. S. Paules, C. S. Downes, and W. K. Kaufmann
The human decatenation checkpoint
PNAS, September 26, 2001; (2001) 221430898.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. T. Abraham
Cell cycle checkpoint signaling through the ATM and ATR kinases
Genes & Dev., September 1, 2001; 15(17): 2177 - 2196.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. J. Huber, T. W. Yang, C. J. Sarkisian, S. R. Master, C.-X. Deng, and L. A. Chodosh
Impaired DNA Damage Response in Cells Expressing an Exon 11-Deleted Murine Brca1 Variant That Localizes to Nuclear Foci
Mol. Cell. Biol., June 15, 2001; 21(12): 4005 - 4015.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Gatei, B.-B. Zhou, K. Hobson, S. Scott, D. Young, and K. K. Khanna
Ataxia Telangiectasia Mutated (ATM) Kinase and ATM and Rad3 Related Kinase Mediate Phosphorylation of Brca1 at Distinct and Overlapping Sites. IN VIVO ASSESSMENT USING PHOSPHO-SPECIFIC ANTIBODIES
J. Biol. Chem., May 11, 2001; 276(20): 17276 - 17280.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. B. Deming, C. A. Cistulli, H. Zhao, P. R. Graves, H. Piwnica-Worms, R. S. Paules, C. S. Downes, and W. K. Kaufmann
The human decatenation checkpoint
PNAS, October 9, 2001; 98(21): 12044 - 12049.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.